Afatinib in Patients with Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT06648096 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Fanconi Anemia
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Afatinib

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Collaborators

[object Object]